Semaglutide vs Tirzepatide Reconstitution Math — Compared Side by Side
What's Actually Different
The reconstitution method is identical for both — convert mg to mcg, divide by diluent volume, convert to syringe units. What differs is the vial sizes you'll see and therefore the concentrations you land on. Semaglutide research vials are commonly 2mg and 5mg; tirzepatide commonly 5mg, 10mg, and 15mg. That difference is where people switching between the two get tripped up.
This page puts them next to each other. For the full per-peptide tables, use the semaglutide calculator and the tirzepatide calculator.
Same Vial, Same Diluent — Different Peptide, Same Math
The math doesn't care which peptide it is. A 5mg vial in 2mL is 2500 mcg/mL whether it's semaglutide or tirzepatide:
5mg × 1000 = 5000 mcg ÷ 2 mL = 2500 mcg/mL = 25 mcg per unit (U-100)
So if both peptides come in a 5mg vial and you reconstitute both in 2mL, the per-unit math is the same. The confusion comes entirely from the different vial sizes each is typically sold in.
The formula itself — (mg × 1000 mcg/mg) ÷ mL diluent = mcg/mL final concentration — applies universally to both molecules. The peptide identity changes nothing about the arithmetic. What changes is the starting vial size and the downstream practical implications for measurement accuracy and reproducibility.
Concentration at 2mL Diluent — Side by Side
| Vial Size | Peptide | Concentration (2mL) | mcg per unit | |-----------|---------|---------------------|--------------| | 2mg | Semaglutide (common) | 1000 mcg/mL | 10 mcg | | 5mg | Semaglutide / Tirzepatide | 2500 mcg/mL | 25 mcg | | 10mg | Tirzepatide (common) | 5000 mcg/mL | 50 mcg | | 15mg | Tirzepatide (common) | 7500 mcg/mL | 75 mcg |
Notice the 5mg row is shared — that's the overlap where the two peptides reconstitute identically. Above and below it, you're in territory specific to one or the other.
The Cross-Up Errors
Carrying over the wrong vial size. Someone used to tirzepatide 10mg vials grabs a semaglutide 2mg vial, reconstitutes "the usual 2mL," and assumes 50 mcg per unit. It's actually 10 mcg per unit — a 5× difference. The habit is the hazard. Recompute every time the vial size changes. This is the single most common error in multi-peptide research environments.
Assuming a fixed "units per dose" transfers. Because the peptides are used at different microgram amounts and come in different vial sizes, a unit count that was right for one is rarely right for the other. Units are meaningless without the concentration behind them. A 10-unit injection of semaglutide from a 2mg vial is 100 mcg; the same 10 units from a 5mg vial is 250 mcg. The syringe marking stayed the same; the payload doubled.
Forgetting the 15mg fractional-unit problem. Tirzepatide 15mg in 2mL gives 7500 mcg/mL, or 75 mcg per unit, which makes many research amounts land on fractional units (e.g. 6.7 units for a 500 mcg dose). Semaglutide rarely hits this because its vial sizes are smaller. If you switch to a 15mg tirzepatide vial, consider 3mL diluent for rounder numbers — 15mg ÷ 3mL = 5000 mcg/mL = 50 mcg per unit. This single choice eliminates measurement friction.
Mishandling the vial during reconstitution. Both peptides are lyophilized (freeze-dried) and sensitive to mechanical stress. The diluent (sterile bacteriostatic water with 0.9% benzyl alcohol per USP <71> standards) must be drawn up and injected gently into the vial. Do not shake; gentle swirling over 1–2 minutes allows the powder to hydrate. Vigorous agitation can damage the peptide backbone and reduce potency below the claimed concentration. This is true regardless of whether the vial contains 2mg or 15mg.
Which Diluent Volume to Pick
The goal is the same for both peptides: a concentration that puts your research amounts in the easy-to-measure 5–30 unit range. Most U-100 insulin syringes have markings every 0.5 unit; below 5 units, accuracy drops; above 30 units, you need multiple injections or a larger-capacity syringe.
- Small vials (2mg semaglutide): 1mL keeps per-unit amounts meaningful; 2mL is fine if your amounts are larger. A 2mg vial reconstituted in 1mL gives 20 mcg per unit — appropriate for research amounts in the 100–200 mcg range.
- Mid vials (5mg either): 2mL is the clean default — 25 mcg per unit. This concentration sits in the middle of the practical range for most research protocols.
- Large vials (10–15mg tirzepatide): 2mL works for 10mg (50 mcg/unit); for 15mg, 3mL avoids fractional units and keeps per-unit amounts at 50 mcg.
Reconstitution also depends on storage stability. Once reconstituted with bacteriostatic water, both peptides should be stored at 2–8°C (refrigerated). Semaglutide remains stable for 28 days after reconstitution under these conditions; tirzepatide, similarly, for up to 28 days. Diluent concentration does not meaningfully alter this window, so choose based on measurement convenience rather than stability concerns.
Quick Decision Table
| If you have… | Reconstitute in | You get | Best for | |--------------|-----------------|---------|----------| | Semaglutide 2mg | 1mL | 20 mcg/unit | 100–300 mcg doses | | Semaglutide 5mg | 2mL | 25 mcg/unit | 150–400 mcg doses | | Tirzepatide 5mg | 2mL | 25 mcg/unit | 150–400 mcg doses | | Tirzepatide 10mg | 2mL | 50 mcg/unit | 250–750 mcg doses | | Tirzepatide 15mg | 3mL | 50 mcg/unit | 250–1000 mcg doses |
How Does Benzyl Alcohol Affect Stability?
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, per USP <71> monograph specifications. This concentration (0.9%, or 9 mg/mL in the diluent) prevents bacterial and fungal contamination during the 28-day refrigerated window post-reconstitution. Both semaglutide and tirzepatide are compatible with this concentration — the alcohol does not degrade the peptide backbone or reduce activity. However, benzyl alcohol is not suitable for intravenous infusion in neonates (due to toxicity concerns not relevant to research use), and it carries a slight odor; this is normal and expected. Do not substitute saline, distilled water, or alcohol-free bacteriostatic water without confirming compatibility with your institution's protocols.
What Happens If You Use the Wrong Diluent?
Saline (0.9% sodium chloride) is isotonic but lacks preservative action. A peptide reconstituted in saline can support bacterial growth within hours at room temperature and is unsuitable for multi-dose vials. Sterile water (without benzyl alcohol) has the same limitation. Distilled water is hypotonic and can cause osmotic cell lysis if the solution contacts living tissue — it is never appropriate for research peptide reconstitution. Using any of these three in place of bacteriostatic water violates both USP <85> (sterile compounding standards) and basic microbial control. Always verify the label: "bacteriostatic water" explicitly, with 0.9% benzyl alcohol listed.
Common Mistakes to Avoid
Confusing mg and mcg — 1mg = 1000 mcg, for both peptides, every time. Write it out during calculation to catch errors before they reach the vial.
Reusing a unit count across peptides without re-deriving concentration from the actual vial size in hand. The same syringe stroke delivers different doses from different concentrations.
Shaking to dissolve — swirl gently for both; shaking denatures the peptide. Use slow, deliberate wrist circles for 1–2 minutes; do not create foam.
Leaving the reconstituted vial at room temperature. Both peptides must be refrigerated at 2–8°C after reconstitution. Unrefrigerated storage accelerates degradation and allows bacterial colonization.
Failing to label the vial with reconstitution date and concentration. A vial sitting in the fridge loses its context quickly. Write the date, concentration in mcg/mL, and expiration (28 days out) on the label immediately after reconstitution.
Where to Source Bacteriostatic Water
Both peptides reconstitute with sterile bacteriostatic water (0.9% benzyl alcohol). Distilled water and saline are not substitutes — see bacteriostatic water vs sterile water vs saline.
- BAC Water Depot — per-lot COA, US-shipped 10mL vials.
- Peptide Sciences — bacteriostatic water alongside research peptides.
- Limitless Life — bacteriostatic water and related research supplies.
When ordering, confirm the vial size (10mL is standard) and that the label explicitly states "bacteriostatic water, 0.9% benzyl alcohol." Some vendors stock both bacteriostatic and sterile water; the difference is critical.
Concentration Changes Across Diluent Volumes — Why It Matters
The same peptide vial yields different final concentrations depending on diluent volume. A 10mg tirzepatide vial becomes either 5000 mcg/mL (in 2mL), 3333 mcg/mL (in 3mL), or 2000 mcg/mL (in 5mL). Each choice trades off measurement precision against volume convenience. A 5mL reconstitution of a 10mg vial gives lower concentration per unit (20 mcg per U-100 unit), which may reduce measurement error for very small doses but increases injection volume. Most research protocols favor the 2–3mL range for both peptides to balance accuracy and practicality. Document your choice in the lab notebook — do not assume the next operator used the same dilution.
For research use only — not clinical guidance. This content provides calculation methods and reference data. No dosing recommendations are made. Follow your institution's protocols for handling and disposal. Consult a qualified professional for any medical applications.